This is a community-generated profile. If you would like to claim it, please .
Relmada Therapeutics Funding
$26.3M
44 rounds
Relmada Therapeutics is active in the following markets / industries: biotechnology. The company has secured funding across 4 rounds, totaling in an amount of $26.3M. Their most recent funding was raised on May 22, 2014.
Funding Rounds
U
$15100000A
$8000000U
$180000A
$3000000Series AJul 2012
Investors of Relmada Therapeutics
MAMF Ventures
Raja Appachi
An entrepreneurial, driven chief executive with a 26 year expertise in pioneering industries.
www.DoWhistle.com www.WhistleFreights.com
Nico Riggio
CEO/Founder Good indulgence LLC/Ltda & Blissimo
Chief Dreamer Officer, Disruptive Inventor, Investor and entrepreneur.
Ben Franklin Technology Partners of Southeastern Pennsylvania
Rounds
A
BioAdvance
Rounds
A